| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,383 |
5,205 |
$399K |
| 95911 |
|
1,753 |
1,558 |
$243K |
| 95923 |
|
2,257 |
2,254 |
$170K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,070 |
2,933 |
$154K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,232 |
1,232 |
$142K |
| 92540 |
|
1,614 |
1,610 |
$103K |
| 92546 |
|
1,469 |
1,466 |
$92K |
| 95924 |
|
700 |
700 |
$69K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,264 |
502 |
$63K |
| 95819 |
|
235 |
232 |
$63K |
| 92548 |
|
1,241 |
1,238 |
$52K |
| 92537 |
|
1,618 |
1,614 |
$38K |
| 95886 |
|
354 |
269 |
$38K |
| 95813 |
|
102 |
101 |
$23K |
| 93886 |
|
95 |
95 |
$14K |
| 95957 |
|
156 |
120 |
$14K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
24 |
24 |
$11K |
| 95816 |
|
52 |
52 |
$10K |
| 93890 |
|
83 |
83 |
$10K |
| 93040 |
|
753 |
752 |
$7K |
| 92547 |
|
1,405 |
1,401 |
$7K |
| J3415 |
Injection, pyridoxine hcl, 100 mg |
773 |
291 |
$6K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
307 |
123 |
$6K |
| 92588 |
|
143 |
142 |
$5K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
305 |
122 |
$5K |
| 99215 |
Prolong outpt/office vis |
44 |
44 |
$5K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
312 |
124 |
$5K |
| 95921 |
|
91 |
91 |
$4K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
42 |
12 |
$2K |
| J3411 |
Injection, thiamine hcl, 100 mg |
773 |
290 |
$2K |
| J0610 |
Injection, calcium gluconate (fresenius kabi), per 10 ml |
593 |
216 |
$2K |
| T1013 |
Sign language or oral interpretive services, per 15 minutes |
65 |
63 |
$1K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
719 |
275 |
$1K |
| 97035 |
|
103 |
39 |
$856.16 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
1,188 |
476 |
$811.09 |
| J7050 |
Infusion, normal saline solution, 250 cc |
1,158 |
454 |
$734.89 |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
51 |
39 |
$617.26 |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
129 |
38 |
$407.31 |
| 97032 |
|
62 |
24 |
$367.82 |
| 99441 |
|
13 |
12 |
$348.18 |
| J0613 |
Injection, calcium gluconate (wg critical care), not therapeutically equivalent to j0612, 10 mg |
106 |
49 |
$129.85 |
| 36415 |
Collection of venous blood by venipuncture |
201 |
186 |
$43.51 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
30 |
25 |
$28.76 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
178 |
174 |
$0.00 |
| G9578 |
Documentation of signed opioid treatment agreement at least once during opioid therapy |
46 |
42 |
$0.00 |
| G9562 |
Patients who had a follow-up evaluation conducted at least every three months during opioid therapy |
46 |
42 |
$0.00 |